Acetylsalicylic acid inhibits monocyte adhesion to endothelial cells by an antioxidative mechanism

Journal of Cardiovascular Pharmacology

Volumn 43, Issue 4, 2004, Pages 514-521

  Eisele, Guido ^a   Schwedhelm, Edzard ^a   Schieffer, Bernhard ^b   Tsikas, Dimitrios ^b   Böger, Rainer H ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Acetylsalicylic acid; Aspirin; Ibuprofen; Low density lipoprotein; Monocyte adhesion; Oxidative stress; Salicylic acid

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; 8 ISOPROSTAGLANDIN F2 ALPHA; ACETYLSALICYLIC ACID; ANTIOXIDANT; CELL ADHESION MOLECULE; FERRITIN; IBUPROFEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; SALICYLIC ACID; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CELL ADHESION; CELL INTERACTION; CONTROLLED STUDY; DRUG MECHANISM; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MONOCYTE; OXIDATIVE STRESS; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM; CELL LINE; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECT; METABOLISM; PHYSIOLOGY;

ANTIOXIDANTS; ASPIRIN; CELL ADHESION; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; HUMANS; MONOCYTES;

EID: 3042573199     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200404000-00006     Document Type: Article

References (39)

1. Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood. 1994;7:2068-2101.
2. Mutin M, Dignat-George F, Sampol J. Immunologic phenotype of cultured endothelial cells: quantitative analysis of cell surface molecules. Tissue Antigens. 1997;50:449-458.
3. Marui N, Offermann MK, Swerlick R, et al. Vascular cell adhesion molecule-I (VCAM-I) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J Clin Invest. 1993;92:1866-1874.
4. Willam C, Schindler R, Frei U, et al. Increases in oxygen tension stimulate expression of ICAM-I and VCAM-I on human endothelial cells. Am J Physiol. 1999;276:H2044-H2052.
5. Grisham MB, Granger DN, Lefer DJ. Modulation of leukocyte-endothelial interactions by reactive metabolites of oxygen and nitrogen: relevance to ischemic heart disease. Free Radic Biol Med. 1998;25:404-433.
6. Pritchard KA Jr, Groszek L, Smalley DM, et al. Native low-density lipoprotein increases endothelial cell nitric oxide synthase generation of superoxide anion. Circ Res. 1995;77:510-518.
7. Barnes PJ, Karin M. Nuclear factor-κB - A pivotal transcription factor in chronic inflammatory diseases. N Engl J Med. 1997;336:1066-1071.
8. Lin JH, Zhu Y, Liao HL, et al. Induction of vascular cell adhesion molecule-I by low-density lipoprotein. Atherosclerosis. 1996;127:185-194.
9. Brand K, Page S, Rogler G, et al. Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. J Clin Invest. 1996; 97:1715-1722.
10. Schreck R, Albermann K, Baeuerle PA. NF-κB: an oxidative stress-responsive transcription factor of eukaryotic cells. Free Radic Res Commun. 1992;17:221-237.
11. Meyer M, Pahl HL, Baeuerle PA. Regulation of the transcription factors NF-kappa B and AP-I by redox changes. Chem Biol Interact. 1994;91: 91-100.
12. Erl W, Weber C, Wardemann C, et al. Alpha-tocopheryl succinate inhibits monocytic cell adhesion to endothelial cells by suppressing NF-kappa B mobilization. Am J Physiol. 1997;273:H634-H640.
13. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature New Biol. 1971;231:232-235.
14. Patrono C. Aspirin as an antiplatelet drug. N Engl J Med. 1994;330:1287-1294.
15. Hermann M, Kapiotis S, Hofbauer R, et al. Salicylate inhibits LDL oxidation initiated by superoxide/nitric oxide radicals. FEBS Lett. 1999;445: 212-214.
16. Yin MJ, Yamamoto Y, Gaynor RB. The anti-inflammatory agents aspirin and salicylate inhibit the activity of IkB kinase-β. Nature. 1998;396: 77-80.
17. Oberle S, Polte T, Abate A, et al. Aspirin increases ferritin synthesis in endothelial cells. Circ Res. 1998;82:1016-1020.
18. Takahashi K, Sawasaki Y, Hata J, et al. Spontaneous transformation and immortalization of human endothelial cells. In Vitro Cell Dev Biol. 1990; 26:265-274.
19. Suda K, Rothen-Rutishauser B, Gunthert M, et al. Phenotypic characterization of human umbilical vein endothelial (ECV304) and urinary carcinoma (T24) cells: endothelial versus epithelial features. In Vitro Cell Dev Biol Anim. 2001;37:505-514.
20. Takahashi K, Sawasaki Y. Rare spontaneously transformed human endothelial cell line provides useful research tool. In Vitro Cell Dev Biol. 1992; 28:380-382.
21. Tsuchiya S, Yamabe M, Yamaguchi Y, et al. Establishment and characterization of a human acute monocytic leukaemia cell line (THP-1). Int J Cancer. 1980;26:171-176.
22. Lowry OH, Rosebrough NJ, Farr AL, et al. Protein measurement with Folin phenol reagent. J Biol Chem. 1951;193:265-275.
23. Bucolo G, David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem. 1973;19:476-482.
24. Esterbauer M, Striegel G, Puhl H, et al. Continuous monitoring of in vitro oxidation of low density lipoprotein. Free Radic Res Commun. 1989;6: 67-75.
25. Chan JR, Böger RH, Bode-Böger SM, et al. Asymmetric dimethylarginine increases mononuclear cell adhesiveness in hypercholesterolemic humans. Arterioscler Thromb Vasc Biol. 2000;20:1040-1046.
26. Schwedhelm E, Tsikas D, Durand T, et al. Tandem mass spectrometric quantification of 8-iso-prostaglandin F2alpha and its metabolite 2,3-dinor-5,6-dihydro-8-iso-prostaglandin F2alpha in human urine. J Chromatogr B. 2000;744:99-112.
27. Marrero MB, Schieffer B, Paxton WG, et al. Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor. Nature. 1995;375: 247-250.
28. Kellogg EW, Fridovich I. Superoxide, hydrogen peroxide, and singlet oxygen in lipid peroxidation by a xanthine oxidase system. J Biol Chem. 1975;250:8812-8817.
29. Böger RH, Bode-Böger SM, Kuhn M, et al. Interaction of superoxide anions with activation of soluble guanylyl cyclase by glyceryl trinitrate, linsidomine, and sodium nitroprusside. Pharm Pharmacol Lett. 1995;5: 10-13.
30. Antithrombotic Trialists Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324:71-86.
31. Kopp E, Ghosh S. Inhibition of NF-κB by sodium salicylate and aspirin. Science. 1994;265:956-959.
32. Latta G, Schmidt N, Nagelschmitz J. Randomised study on the relative bioavailability of the new acetylsalicylic acid (ASA) dry granules 500 mg in comparison to the 500 mg ASA plain tablet [abstract]. Br J Clin Pharmacol. 1999;48(Suppl 60):632.
33. Marui N, Offerman MK, Swerlik R. Vascular cell adhesion molecule-I gene transcription and expression are regulated through an antioxidant-sensitive mechanisms in human vascular endothelial cells. J Clin Invest. 1993;92:1866-1874.
34. Weber C, Erl W, Pielsch A, et al. Aspirin inhibits nuclear factor-kappa B mobilization and monocyte adhesion in stimulated human endothelial cells. Circulation. 1995;91:1914-1917.
35. Patel RP, Moellering D, Murphy-Ullrich J, et al. Cell signaling by reactive nitrogen and oxygen species in atherosclerosis. Free Radic Biol Med. 2000;28:1780-1794.
36. Podhaisky HP, Abate A, Polte T, et al. Aspirin protects endothelial cells from oxidative stress: possible synergism with vitamin E. FEBS Lett. 1997;417:349-351.
37. Ranke C, Hecker H, Creutzig A, et al. Dose-dependent effect of aspirin on carotid atherosclerosis. Circulation. 1993;87:1873-1879.
38. Jaffe EA, Weksler BB. Recovery of endothelial cell prostacyclin production after inhibition by low doses of aspirin. J Clin Invest. 1979;63:532-535.
39. Pedersen AK, Fitzgerald GA. Dose-related kinetics of aspirin - presystemic acetylation of platelet cyclooxygenase. N Engl J Med. 1984;311: 1206-1211.